Last reviewed · How we verify
NCT05135260
Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic
NA trial testing Virtual reality therapy in Cancer in 99 participants. Completed in 16 December 2023.
16 December 2023
Quick facts
| Lead sponsor | Cody Stansel |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 99 |
| Start date | 1 November 2021 |
| Primary completion | 16 December 2023 |
| Estimated completion | 16 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Virtual reality therapy
- Questionnaires
- Measure heart rate
- Cyber sickness measurement
Conditions studied
- Cancer — all drugs for Cancer →
- Chemotherapy — all drugs for Chemotherapy →
Sponsor
Cody Stansel
Who can join
18 and older, any sex, with Cancer or Chemotherapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will investigate the ability of virtual reality to function as a novel distraction intervention and improve the experience of patients who are receiving chemotherapy in the infusion clinic.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Virtual Reality on Pain, Stress, and Affect in an Outpatient Chemotherapy Infusion Clinic: A Randomized Controlled Trial.
Stansel CC, McLeod AR, Gulati S, Ivory CH, et al · · 2025 · cited 6× · PMID 39933083 · DOI 10.1188/25.cjon.65-71
Verify or expand the search:
- PubMed search for NCT05135260
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Virtual reality therapy
Trials testing the same drug.
- NCT06385574 — Technological Based Rehabilitation on Individuals With Rheumatic Disease · NA · recruiting
- NCT06241534 — Supporting Methods in Cardiovascular Diseases Rehabilitation · NA · completed
- NCT06215456 — Virtual Reality to Reduce Periprocedural Anxiety During Invasive Coronary Angiography · NA · unknown
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05135260 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cody Stansel
- Last refreshed: 16 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05135260.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing